Immunologiya

Aims & Scope

The journal covers major theoretical and practical issues in general and applied immunology and allergology.

It disseminates the results of original research in the fields of immunogenetics, molecular and cellular immunology, immunochemistry, immunomorphology, clinical immunology, and immunopathology.

The journal publishes articles on the biochemical aspects of immunogenesis and immunological aspects of allergy, new methods of immunological and immunochemical analysis that may be recommended for use in clinical and experimental settings, and the functional basis of the immune system.

It also publishes short communications containing novel findings that may improve practice in clinical and experimental immunology and allergology, book reviews, and information on congresses, conferences, and anniversaries.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Immunomodulators: myths and reality

  Citation: 23

  Authors: R.M.

• Immunopathogenic properties of SARS-CoV-2 as a basis for the choice of pathogenetic therapy

  Citation: 21

  Authors: M.P.

• Immune response against epidemic coronaviruses

  Citation: 18

  Authors: M.V., R.M.

• Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection

  Citation: 15

  Authors: G.O., R.M., D.A., M.R.

• Glucosaminylmuramyldipeptide - GMDP: effect on mucosal immunity (on the issue of immunotherapy and immunoprophylaxis)

  Citation: 13

  Authors: S.V., R.M.

• A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV

  Citation: 10

  Authors: A.V., I.V., D.M., M.V., A.G., L.V., I.V., S.A., O.V., T.A., O., A.I., E.A., Ya.V., I.B., D.V., I.M., P.G., S.V., B.S., D.Yu., A.L.

• The use of the ELISPOT technological platform in the diagnosis of tuberculosis infection in patients with HIV infection

  Citation: 8

  Authors: E.A., D.A., A.N., E.P., E.V.

• Role of IL-25, IL-33 and TSLP in the development of corticosteroid resistance

  Citation: 6

  Authors: A.S., N.N., I.P., A.G., A.D., G.O., M.R.

• Effect of local suppression of Stat3 gene expression in a mouse model of pulmonary neutrophilic inflammation

  Citation: 6

  Authors: A.A., I.P., K.V., L.I., E.D., V.I., A.V., V.N., M.M., V.E., A.A., I.B., I.A., I.V., A.V., O.A., D.A., M.R.

• Epstein-Barr virus: vaccine development

  Citation: 6

  Authors: T.V., T.A., N.N., M.P., N.I.